Catalyst Wire Dossier Catalyst Wire Dossier

SARCLISA

isatuximab · Sanofi-Aventis U.S. LLC
Drug timelines are a Plus or Pro feature.

41 regulatory and trial events tracked for SARCLISA, covering 2020-03-02 to 2026-07-07. Get the full timeline:

Most recent: EMA Authorised: Sarclisa (Isatuximab) — Sanofi Winthrop Industrie

See pricing